Stock Comparison
GH vs IDXX
Guardant Health Inc and IDEXX Laboratories Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$19.79B
$43.50B
P/E (TTM)
—
40.6
Forward P/E
—
37.5
Price/Sales
18.3
9.8
Price/Book
55.7
28.0
EV/EBITDA
-5.4
28.5
Dividend Yield
—
—
Profitability
Net Margin
-40.10%
24.60%
Operating Margin
-40.20%
31.80%
Return on Equity
-4584.00%
72.90%
Return on Assets
-17.20%
26.50%
Growth (YoY)
Revenue Growth
48.30%
14.30%
Earnings Growth
0.00%
17.20%
Price & Risk
Beta
1.6
1.5
52-Week High
$151.85
$769.98
52-Week Low
$40.35
$506.91
Analyst Target
$144.42
$709.14
Compare GH and IDXX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.